Bezafibrate improves bacterial lipopolysaccharide-induced dyslipidemia and anorexia in rats

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 517-522

  Harada, Nagakatsu ^a   Kusuyama, Akiko ^a   Morishima, Masaki ^a   Okada, Kazuko ^a   Takahashi, Akira ^a   Nakaya, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BEZAFIBRATE; LEPTIN; MESSENGER RNA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BACTERIAL INFECTION; BODY WEIGHT; CACHEXIA; CREAM; DYSLIPIDEMIA; ENDOTOXEMIA; ENERGY EXPENDITURE; GENE EXPRESSION; HORMONE BLOOD LEVEL; LIPID METABOLISM; MALE; METABOLIC DISORDER; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY QUOTIENT; SHORT COURSE THERAPY; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ANIMALS; ANOREXIA; ANTILIPEMIC AGENTS; BEZAFIBRATE; BLOOD GLUCOSE; BLOOD PROTEINS; BLOTTING, NORTHERN; BODY WEIGHT; DYSLIPIDEMIAS; ENERGY METABOLISM; ION CHANNELS; LIPOPOLYSACCHARIDES; LIPOPROTEIN LIPASE; MALE; MITOCHONDRIAL PROTEINS; MUSCLE PROTEINS; ORGAN SIZE; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 33947210224     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.11.011     Document Type: Article

References (29)

1. Tisdale M.J. Cachexia in cancer patients. Nat Rev Cancer 2 (2002) 862-871
2. Kern K.A., and Norton J.A. Cancer cachexia. JPEN J Parenter Enteral Nutr 12 (1988) 286-298
3. Fong Y., Moldawer L.L., Marano M., et al. Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. Am J Physiol 256 (1989) R659-R665
4. Legaspi A., Jeevanandam M., Starnes Jr. H.F., et al. Whole body lipid and energy metabolism in the cancer patient. Metabolism 36 (1987) 958-963
5. Bagby G.J., Corll C.B., and Martinez R.R. Triacylglycerol kinetics in endotoxic rats with suppressed lipoprotein lipase activity. Am J Physiol 253 (1987) E59-E64
6. Feingold K.R., Staprans I., Memon R.A., et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33 (1992) 1765-1776
7. Bagby G.J., and Spitzer J.A. Lipoprotein lipase activity in rat heart and adipose tissue during endotoxic shock. Am J Physiol 238 (1980) H325-H330
8. Bagby G.J., and Spitzer J.A. Decreased myocardial extracellular and muscle lipoprotein lipase activities in endotoxin-treated rats. Proc Soc Exp Biol Med 168 (1981) 395-398
9. Hataya Y., Akamizu T., Hosoda H., et al. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144 (2003) 5365-5371
10. Kawamura I., Yamamoto N., Sakai F., et al. Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice. Anticancer Res 19 (1999) 4099-4103
11. Vazquez M., Roglans N., Cabrero A., et al. Bezafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal beta-oxidation in rat white adipose tissue. Mol Cell Biochem 216 (2001) 71-78
12. Staels B., Dallongeville J., Auwerx J., et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98 (1998) 2088-2093
13. Nakaya Y., Ishimura N., Takishita E., et al. Chronic feeding of a nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in type 2 diabetic model rats, Otsuka Long-Evans Tokushima Fatty rats, but not in nondiabetic rats. Metabolism 51 (2002) 702-707
14. Berbee J.F., Havekes L.M., and Rensen P.C. Apolipoproteins modulate the inflammatory response to lipopolysaccharide. J Endotoxin Res 11 (2005) 97-103
15. Aspichueta P., Perez-Agote B., Perez S., et al. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver. J Endotoxin Res 12 (2006) 181-192
16. Gouni I., Oka K., Etienne J., et al. Endotoxin-induced hypertriglyceridemia is mediated by suppression of lipoprotein lipase at a post-transcriptional level. J Lipid Res 34 (1993) 139-146
17. Hill M.R., Kelly K., Wu X., et al. Lipopolysaccharide regulation of lipoprotein lipase expression in murine macrophages. Infect Immun 63 (1995) 858-864
18. Kobayashi J., Takahashi K., Tashiro J., et al. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. Arzneimittelforschung 44 (1994) 145-148
19. Peters J.M., Aoyama T., Burns A.M., et al. Bezafibrate is a dual ligand for PPAR alpha and PPAR beta: studies using null mice. Biochim Biophys Acta 1632 (2003) 80-89
20. Puigserver P., Rhee J., Lin J., et al. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPAR gamma coactivator-1. Mol Cell 8 (2001) 971-982
21. Bezaire V., Spriet L.L., Campbell S., et al. Constitutive UCP3 overexpression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation. FASEB J 19 (2005) 977-979
22. Bing C., Brown M., King P., et al. Increased gene expression of brown fat uncoupling protein (UCP)1 and skeletal muscle UCP2 and UCP3 in MAC16-induced cancer cachexia. Cancer Res 60 (2000) 2405-2410
23. Son C., Hosoda K., Matsuda J., et al. Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes. Endocrinology 142 (2001) 4189-4194
24. Friedman G., Gallily R., Chajek-Shaul T., et al. Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim Biophys Acta 960 (1988) 220-228
25. Takano H., Nagai T., Asakawa M., et al. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes. Circ Res 87 (2000) 596-602
26. Berkowitz D.E., Brown D., Lee K.M., et al. Endotoxin-induced alteration in the expression of leptin and beta3-adrenergic receptor in adipose tissue. Am J Physiol 274 (1998) E992-E997
27. Francis J., MohanKumar P.S., MohanKumar S.M., et al. Systemic administration of lipopolysaccharide increases plasma leptin levels: blockade by soluble interleukin-1 receptor. Endocrine 10 (1999) 291-295
28. Cammisotto P.G., and Bukowiecki L.J. Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol 283 (2002) C244-C250
29. Mulet T., Pico C., Oliver P., et al. Blood leptin homeostasis: sex-associated differences in circulating leptin levels in rats are independent of tissue leptin expression. Int J Biochem Cell Biol 35 (2003) 104-110